JHepatol[Jour]AND73[volume]AND1[issue]
肝病学杂志73卷1期
1
Anewdefinitionformetabolicdysfunction-associatedfattyliverdisease:Aninternationalexpertconsensusstatement.
代谢功能障碍相关脂肪性肝病的新定义：国际专家共识声明。
EslamM,NewsomePN,SarinSK,AnsteeQM,TargherG,Romero-GomezM,Zelber-SagiS,Wai-SunWongV,DufourJF,SchattenbergJM,KawaguchiT,ArreseM,ValentiL,ShihaG,TiribelliC,Yki-J?rvinenH,FanJG,Gr?nb?kH,YilmazY,Cortez-PintoH,OliveiraCP,BedossaP,AdamsLA,ZhengMH,FouadY,ChanWK,Mendez-SanchezN,AhnSH,CasteraL,BugianesiE,RatziuV,GeorgeJ.
JHepatol.Jul;73(1):-.
2
Innateimmunecellsincirrhosis.
肝硬化的先天免疫细胞。
BernsmeierC,vanderMerweS,PérianinA.
JHepatol.Jul;73(1):-.
3
Moleculartargetedtherapies:Readyfor"primetime"inbiliarytractcancer.
分子靶向治疗：为胆管癌的“*金时期”做好准备。
LamarcaA,BarriusoJ,McNamaraMG,ValleJW.
JHepatol.Jul;73(1):-.
4
Stereotacticbodyradiationtherapyvs.radiofrequencyablationinAsianpatientswithhepatocellularcarcinoma.
立体定向体部放射治疗与射频消融术在亚洲肝癌患者中的应用。
KimN,ChengJ,JungI,LiangJ,ShihYL,HuangWY,KimuraT,LeeVHF,ZengZC,ZhengganR,KayCS,HeoSJ,WonJY,SeongJ.
JHepatol.Jul;73(1):-.
5
Selonsertibforpatientswithbridgingfibrosisor